135 related articles for article (PubMed ID: 12888877)
1. Intracellular activation of the fibrinolytic cascade in the Quebec Platelet Disorder.
Sheth PM; Kahr WH; Haq MA; Veljkovic DK; Rivard GE; Hayward CP
Thromb Haemost; 2003 Aug; 90(2):293-8. PubMed ID: 12888877
[TBL] [Abstract][Full Text] [Related]
2. Platelets from patients with the Quebec platelet disorder contain and secrete abnormal amounts of urokinase-type plasminogen activator.
Kahr WH; Zheng S; Sheth PM; Pai M; Cowie A; Bouchard M; Podor TJ; Rivard GE; Hayward CP
Blood; 2001 Jul; 98(2):257-65. PubMed ID: 11435291
[TBL] [Abstract][Full Text] [Related]
3. Quebec platelet disorder: features, pathogenesis and treatment.
Diamandis M; Veljkovic DK; Maurer-Spurej E; Rivard GE; Hayward CP
Blood Coagul Fibrinolysis; 2008 Mar; 19(2):109-19. PubMed ID: 18277131
[TBL] [Abstract][Full Text] [Related]
4. Increased expression of urokinase plasminogen activator in Quebec platelet disorder is linked to megakaryocyte differentiation.
Veljkovic DK; Rivard GE; Diamandis M; Blavignac J; Cramer-Bordé EM; Hayward CP
Blood; 2009 Feb; 113(7):1535-42. PubMed ID: 19029443
[TBL] [Abstract][Full Text] [Related]
5. Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis.
Diamandis M; Adam F; Kahr WH; Wang P; Chorneyko KA; Arsenault AL; Rivard GE; Hayward CP
J Thromb Haemost; 2006 May; 4(5):1086-94. PubMed ID: 16689763
[TBL] [Abstract][Full Text] [Related]
6. Inherited disorders of the fibrinolytic pathway.
Jain S; Acharya SS
Transfus Apher Sci; 2019 Oct; 58(5):572-577. PubMed ID: 31427261
[TBL] [Abstract][Full Text] [Related]
7. Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment.
Blavignac J; Bunimov N; Rivard GE; Hayward CP
Semin Thromb Hemost; 2011 Sep; 37(6):713-20. PubMed ID: 22102275
[TBL] [Abstract][Full Text] [Related]
8. Activation of single-chain urokinase-type plasminogen activator by platelet-associated plasminogen: a mechanism for stimulation of fibrinolysis by platelets.
Baeten KM; Richard MC; Kanse SM; Mutch NJ; Degen JL; Booth NA
J Thromb Haemost; 2010 Jun; 8(6):1313-22. PubMed ID: 20180903
[TBL] [Abstract][Full Text] [Related]
9. Platelet-dependent thrombin generation after in vitro fibrinolytic treatment.
Aronson DL; Chang P; Kessler CM
Circulation; 1992 May; 85(5):1706-12. PubMed ID: 1533349
[TBL] [Abstract][Full Text] [Related]
10. Plasminogen activator in acute myeloid leukaemic marrows: u-PA in contrast to t-PA in normal marrow.
McWilliam N; Robbie L; Booth N; Bennett B
Br J Haematol; 1998 Jun; 101(4):626-31. PubMed ID: 9674732
[TBL] [Abstract][Full Text] [Related]
11. Aggregation of washed platelets by plasminogen and plasminogen activators is mediated by plasmin and is inhibited by a synthetic peptide disulfide.
Puri RN; Hu CJ; Matsueda R; Umeyama H; Colman RW
Thromb Res; 1992 Mar; 65(4-5):533-47. PubMed ID: 1535463
[TBL] [Abstract][Full Text] [Related]
12. Post-traumatic plasminogenesis in intraarticular exudate in the knee joint.
Rość D; Powierza W; Zastawna E; Drewniak W; Michalski A; Kotschy M
Med Sci Monit; 2002 May; 8(5):CR371-8. PubMed ID: 12011780
[TBL] [Abstract][Full Text] [Related]
13. Characterization and antithrombotic action of tissue plasminogen activator.
Bergqvist D; Nilsson IM; Pandolfi M
Experientia; 1984 Jan; 40(1):67-8. PubMed ID: 6229416
[TBL] [Abstract][Full Text] [Related]
14. Fluorogenic fibrinogen and fibrin facilitate macromolecular assembly and dynamic assay of picomolar levels of plasminogen activators under well mixed conditions.
Wu JH; Diamond SL
Thromb Haemost; 1995 Aug; 74(2):711-7. PubMed ID: 8585011
[TBL] [Abstract][Full Text] [Related]
15. Molecular basis of fibrinolysis, as relevant for thrombolytic therapy.
Collen D; Lijnen HR
Thromb Haemost; 1995 Jul; 74(1):167-71. PubMed ID: 8578451
[TBL] [Abstract][Full Text] [Related]
16. Quebec platelet disorder.
Hayward CP; Rivard GE
Expert Rev Hematol; 2011 Apr; 4(2):137-41. PubMed ID: 21495923
[TBL] [Abstract][Full Text] [Related]
17. Excess soluble urokinase-type plasminogen activator receptor in the plasma of dialysis patients correlates with increased fibrinolytic activity.
Pawlak K; Pawlak D; Mysliwiec M
Thromb Res; 2007; 119(4):475-80. PubMed ID: 16828495
[TBL] [Abstract][Full Text] [Related]
18. Bleeding risks associated with inheritance of the Quebec platelet disorder.
McKay H; Derome F; Haq MA; Whittaker S; Arnold E; Adam F; Heddle NM; Rivard GE; Hayward CP
Blood; 2004 Jul; 104(1):159-65. PubMed ID: 15026313
[TBL] [Abstract][Full Text] [Related]
19. Actin stimulates plasmin generation by tissue and urokinase-type plasminogen activators.
Lind SE; Smith CJ
Arch Biochem Biophys; 1993 Nov; 307(1):138-45. PubMed ID: 8239651
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the relative fibrinogenolytic, fibrinolytic and thrombolytic properties of tissue plasminogen activator and urokinase in vitro.
Matsuo O; Rijken DC; Collen D
Thromb Haemost; 1981 Jun; 45(3):225-9. PubMed ID: 7025339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
